Publications by authors named "S B Pal"

Background: Melioidosis cases are increasing in Southeast Asia, posing a significant challenge owing to the rising number of diabetic and immune compromised patients. Pneumonia is the most common presentation of melioidosis, while cutaneous melioidosis is rare.

Objectives: We report a case of primary cutaneous melioidosis (PCM) that eventually required intensive care unit (ICU) management.

View Article and Find Full Text PDF

This paper analyzes the effects of private practice on public health provision in Indonesia among doctor heads of primary public health clinics known as puskesmas. We exploit the exogenous variation in the initiation of private practice after the 1997 Ministry of Health regulation 916 that mandated health professionals to apply for a license for private practice after at least three years of compulsory public service after graduation. Instrumental variable estimates, built around this threshold experience of 3 years after 1997 regulation, suggest that dual practitioners (relative to those only engaged in puskesmas) work significantly fewer hours per week at their public posts at the puskesmas but see significantly more public patients.

View Article and Find Full Text PDF

Evaluating fish habitat suitability (FHS) is of utmost importance in the present times, as rising pollution and ecological stress have led to the deterioration of their habitat and population. The present study has evaluated ecological water quality using the comprehensive pollution index (CPI), eutrophication index (EI), and organic pollution index (OPI). Fish community structure has been assessed based on tropic level score (TLC) and habitat orientation score (HOS).

View Article and Find Full Text PDF

Background: The emergence of -deleted parasites threatens histidine-rich protein 2 (HRP2)-based malaria rapid diagnostic test (RDT) performance. RDTs targeting () lactate dehydrogenase (LDH) may address current product limitations and improve case management.

Objectives: To evaluate the performance and usability of three LDH-based RDTs in febrile patients.

View Article and Find Full Text PDF

Background: In the phase 3 JAVELIN Renal 101 trial (NCT02684006), first-line treatment with avelumab + axitinib resulted in significantly longer progression-free survival (PFS) and a higher objective response rate (ORR) vs sunitinib in patients with advanced renal cell carcinoma (aRCC). We report the final analysis, including the primary analysis of overall survival (OS).

Patients And Methods: Patients with untreated aRCC (any prognostic risk score) were enrolled.

View Article and Find Full Text PDF